Crotonyl fentanyl Property

solubility 

DMF: 30 mg/ml; DMSO: 20 mg/ml; Ethanol: 30 mg/ml; PBS (pH 7.2): 10 mg/ml

form 

A neat solid

Safety

DEA Controlled Substances

CSCN: 9844
CSA SCH: Schedule I
NARC: Yes

Hazard and Precautionary Statements (GHS)

Symbol(GHS)

Signal word

Warning

Hazard statements

H302Harmful if swallowed

H312Harmful in contact with skin

H332Harmful if inhaled

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P271Use only outdoors or in a well-ventilated area.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.

P312Call a POISON CENTER or doctor/physician if you feel unwell.

P322Specific measures (see …on this label).

P330Rinse mouth.

P363Wash contaminated clothing before reuse.

P501Dispose of contents/container to..…

Crotonyl fentanyl Chemical Properties,Usage,Production

Description

Crotonyl fentanyl is an analytical reference material categorized as an opioid.^1,2,3 Crotonyl fentanyl induces generalized responses in mice trained to discriminate oxycodone from saline.⁴ Crotonyl fentanyl is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.

Uses

Crotonyl Fentanyl is an analog of Fentanyl (F274990), which is a controlled substanced used as analgesic.

References

1. Eshleman, A.J., Nagarajan, S., Wolfrum, K.M., et al. Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors Biochem. Pharmacol. 182,114293(2020).
2. Vasudevan, L., Vandeputte, M.M., Deventer, M., et al. Assessment of structure-activity relationships and biased agonism at the mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform Biochem. Pharmacol. 177,113910(2020).
3. Varshneya, N.B., Walentiny, D.M., Moisa, L.T., et al. Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances Neuropharmacology 151,171-179(2019).
4. Walentiny, D.M., Moisa, L.T., and Beardsley, P.M. Oxycodone-like discriminative stimulus effects of fentanyl-related emerging drugs of abuse in mice Neuropharmacology 150,210-216(2019).